Exantas Capital (XAN) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

XAN vs. ORC, LAND, CLDT, UHT, OLP, CTO, PKST, FPI, ACRE, and GMRE

Should you be buying Exantas Capital stock or one of its competitors? The main competitors of Exantas Capital include Orchid Island Capital (ORC), Gladstone Land (LAND), Chatham Lodging Trust (CLDT), Universal Health Realty Income Trust (UHT), One Liberty Properties (OLP), CTO Realty Growth (CTO), Peakstone Realty Trust (PKST), Farmland Partners (FPI), Ares Commercial Real Estate (ACRE), and Global Medical REIT (GMRE). These companies are all part of the "finance" sector.

Exantas Capital vs.

Orchid Island Capital (NYSE:ORC) and Exantas Capital (NYSE:XAN) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings.

32.7% of Orchid Island Capital shares are held by institutional investors. Comparatively, 41.8% of Exantas Capital shares are held by institutional investors. 0.5% of Orchid Island Capital shares are held by company insiders. Comparatively, 5.7% of Exantas Capital shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Orchid Island Capital pays an annual dividend of $1.44 per share and has a dividend yield of 17.2%. Exantas Capital pays an annual dividend of $3.30 per share and has a dividend yield of 24.3%. Orchid Island Capital pays out -175.6% of its earnings in the form of a dividend. Exantas Capital pays out 330.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orchid Island Capital
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Exantas Capital
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Orchid Island Capital has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500. Comparatively, Exantas Capital has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500.

In the previous week, Orchid Island Capital had 5 more articles in the media than Exantas Capital. MarketBeat recorded 5 mentions for Orchid Island Capital and 0 mentions for Exantas Capital. Exantas Capital's average media sentiment score of 0.66 beat Orchid Island Capital's score of 0.00 indicating that Orchid Island Capital is being referred to more favorably in the media.

Company Overall Sentiment
Orchid Island Capital Positive
Exantas Capital Neutral

Exantas Capital has lower revenue, but higher earnings than Orchid Island Capital. Orchid Island Capital is trading at a lower price-to-earnings ratio than Exantas Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orchid Island Capital$177.57M2.42-$39.23M-$0.82-10.23
Exantas Capital$61.15M7.13$35.97M$1.0013.59

Orchid Island Capital has a net margin of 0.00% compared to Orchid Island Capital's net margin of -347.93%. Orchid Island Capital's return on equity of 8.10% beat Exantas Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
Orchid Island CapitalN/A -9.13% -0.94%
Exantas Capital -347.93%8.10%1.61%

Orchid Island Capital received 234 more outperform votes than Exantas Capital when rated by MarketBeat users. Likewise, 61.17% of users gave Orchid Island Capital an outperform vote while only 30.89% of users gave Exantas Capital an outperform vote.

CompanyUnderperformOutperform
Orchid Island CapitalOutperform Votes
293
61.17%
Underperform Votes
186
38.83%
Exantas CapitalOutperform Votes
59
30.89%
Underperform Votes
132
69.11%

Summary

Exantas Capital beats Orchid Island Capital on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XAN vs. The Competition

MetricExantas CapitalReal Estate Investment Trusts IndustryFinance SectorNYSE Exchange
Market Cap$436.14M$6.27B$8.41B$17.42B
Dividend Yield21.15%6.89%6.67%3.53%
P/E Ratio-1.9432.5259.8722.97
Price / Sales7.136.053,538.4910.37
Price / Cash1.3416.4027.9917.79
Price / Book0.782.172.374.90
Net Income$35.97M$151.15M$982.34M$964.49M

Exantas Capital Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ORC
Orchid Island Capital
2.1652 of 5 stars
$8.63
+3.7%
N/A-21.6%$442.46M$177.57M-10.522,018Short Interest ↓
LAND
Gladstone Land
2.6827 of 5 stars
$12.75
-0.2%
N/A-22.7%$456.96M$90.40M-47.22N/A
CLDT
Chatham Lodging Trust
3.4524 of 5 stars
$9.51
+1.5%
$13.33
+40.3%
-8.9%$464.80M$311.11M-86.4117
UHT
Universal Health Realty Income Trust
2.5792 of 5 stars
$33.94
+1.3%
N/A-26.8%$468.98M$95.57M30.57N/AShort Interest ↑
News Coverage
OLP
One Liberty Properties
2.8486 of 5 stars
$22.73
+0.5%
$25.00
+10.0%
+3.9%$483.01M$90.65M16.4710Upcoming Earnings
CTO
CTO Realty Growth
2.7856 of 5 stars
$17.22
+0.8%
$20.00
+16.1%
+2.1%$392.79M$109.12M574.0033Upcoming Earnings
PKST
Peakstone Realty Trust
2.5579 of 5 stars
$13.90
+4.1%
$21.00
+51.1%
-39.1%$504.71M$254.28M-0.9035Short Interest ↓
News Coverage
FPI
Farmland Partners
3.8719 of 5 stars
$10.85
+0.4%
$15.00
+38.2%
+3.4%$522.43M$57.47M20.8725Upcoming Earnings
ACRE
Ares Commercial Real Estate
3.8685 of 5 stars
$6.81
+2.3%
$8.79
+29.0%
-19.8%$370.60M$88.96M-9.462,800Short Interest ↑
GMRE
Global Medical REIT
3.6776 of 5 stars
$8.19
-0.1%
$11.50
+40.5%
-12.6%$536.69M$141.05M35.5926Short Interest ↑

Related Companies and Tools

This page (NYSE:XAN) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners